A Real World Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3304 participants.
Also called NCT02451137
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,304 participants
- Sponsor
- Registry
-
NCT02451137
-
- Other papers using this trial's data
- Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02451137. Randomized; no masking; primary purpose treatment. Start 2015-06-16 (actual); primary completion 2018-03-02 (actual). Results posted on 2019-05-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Insulin glargine, 300 U/ml
- Intervention (Drug)
- Insulin glargine, 100 U/ml
- Intervention (Drug)
- Insulin detemir
- Intervention (Drug)
- Background Therapy
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct02451137- Content hash
d40862a1c12448434f33d10269308b6181d994d8f0f7fee6ba271e87bd02b0f1